Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Accolade, Inc. - common stock
(NQ:
ACCD
)
6.900
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,205,009
Open
6.900
Bid (Size)
6.870 (1,000)
Ask (Size)
6.900 (3)
Prev. Close
6.900
Today's Range
6.880 - 6.910
52wk Range
3.080 - 12.93
Shares Outstanding
76,232,192
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
February 08, 2025
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Via
Benzinga
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
January 31, 2025
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Via
Benzinga
Performance
YTD
+101.75%
+101.75%
1 Month
+0.58%
+0.58%
3 Month
+104.14%
+104.14%
6 Month
+61.59%
+61.59%
1 Year
-44.17%
-44.17%
More News
Read More
Cathie Wood's Wednesday Moves: Ark Invest Dumps Robinhood Stock
January 22, 2025
Via
Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
January 22, 2025
Via
Benzinga
Topics
Government
Exposures
Political
Accolade Q3 Earnings Assessment
January 10, 2025
Via
Benzinga
Earnings Scheduled For January 9, 2025
January 09, 2025
Via
Benzinga
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
January 18, 2025
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
January 13, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
January 11, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
What's Going On With Accolade Stock Wednesday?
January 08, 2025
Via
Benzinga
Breaking Down Accolade: 8 Analysts Share Their Views
December 17, 2024
Via
Benzinga
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
January 08, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 08, 2025
Via
Benzinga
Why Is Accolade Stock Trading Over 100% On Tuesday?
January 08, 2025
Via
Benzinga
Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders
January 08, 2025
From
Ademi LLP
Via
Business Wire
Forecasting The Future: 6 Analyst Projections For Accolade
October 09, 2024
Via
Benzinga
Uncovering Potential: Accolade's Earnings Preview
October 07, 2024
Via
Benzinga
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
January 08, 2025
From
Halper Sadeh LLC
Via
Business Wire
Transcarent To Acquire Accolade
January 08, 2025
From
Transcarent
Via
Business Wire
Transcarent To Acquire Accolade
January 08, 2025
From
Accolade, Inc.
Via
GlobeNewswire
Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
October 08, 2024
Via
Benzinga
Accolade Announces Results for Fiscal Second Quarter 2025
October 08, 2024
From
Accolade, Inc.
Via
GlobeNewswire
Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
October 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday
October 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 04, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
